Lifeboat News: The Blog – Safeguarding Humanity

(Video) Researchers Find Promising Alzheimer’s Treatment Using Diabetes Drug

Posted by Brady Hartman in biotech/medical, neuroscience

Jan 2
2018

Researchers find promising Alzheimer’s treatment with a diabetes drug that ‘significantly reversed memory loss.’

Promising alzheimer’s treatment using diabetes drug.

Scientists announced a drug that ‘significantly reversed memory loss’ in mice with Alzheimer’s disease.

Researchers from Lancaster University in the UK say the novel drug – created to treat type 2 diabetes – works through a triple method of action and also add that the medicine could provide substantial improvements in the treatment of Alzheimer’s disease. The drug combines three growth factors that act in multiple ways to protect the brain from degeneration. The Lancaster University scientists published their study results on January 1 in the journal Brain Research.

Continue reading “(Video) Researchers Find Promising Alzheimer’s Treatment Using Diabetes Drug” | >

New Research on Maximum Human Lifespan

Posted by Brady Hartman in genetics, life extension

Jan 2
2018

Summary: New findings on maximum human lifespan shows that we have an upper limit due to the construction of our bodies and genetic constraints. However, anti-aging scientists may have discovered ways to overcome this limitation. [This article first appeared on the LongevityFacts website. Author: Brady Hartman. ]

Three new studies show that maximum human lifespan is limited to about 115 – 120 years due to genetic constraints, the construction of our bodies and an increasingly toxic environment.

These studies are hardly the first to conclude there is a maximum human lifespan. However, there may be a way to overcome this limitation.

Quantum Computing Q — US

Posted by Klaus Baldauf in business, computing, quantum physics

Jan 2
2018

IBM Q is an industry-first initiative to build commercially available universal quantum computers for business and science.

Watch video.

Stem Cell Trials For Osteoarthritis Repair Cartilage

Posted by Steve Hill in biotech/medical, life extension

Jan 2
2018

Mesenchymal stem cells (MSCs) are one of the most thoroughly studied and understood stem cell types. They are used in a wide range of therapies, and the many studies using MSCs have enjoyed varied levels of success, depending on delivery methods, patients, co-therapies and other factors.

Today, we will be taking a look at MSCs and a new human clinical trial focused on treating osteoarthritis, an age-related inflammatory condition that leads to the breakdown of bone and cartilage.

The DGfA Aging Conference and James Peyer Interview

Posted by Steve Hill in biotech/medical, life extension

Jan 2
2018

Victor Björk, biologist and member of the LEAF teama report about a recent aging research conference that he attended in Germany. Victor is one of our more well-traveled writers, and he has the fortune to attend many interesting shows, events, and conferences in Europe. Today Victor reports on the DGfA Aging Conference and also interviews James Peyer from Apollo Ventures, an early-stage life science investor and company builder focused on translational research for age-related diseases.

An annual aging research conference

I took part in the yearly DGfA conference at the Max Planck Institute for Aging Research in Cologne on December 1–2, 2017. The event was organized by the German association for aging research, an interdisciplinary non-profit organization based in Nürnberg. Established in 1990, it conducts research on aging, including research on developing therapeutic options to treat age-related diseases.

2017 End of Year Podcast | NASA

Posted by Odette Bohr Dienel in space

Jan 2
2018

“An end of year compilation of conversations with various NASA scientists, engineers, and researchers throughout 2017 on the NASA in Silicon Valley Podcast.”